Do you want to read an article? Please log in or register.
Cardiovascular-Kidney-Metabolic Medication Eligibility Across National Survey, Community-Based, and Ambulatory Healthcare Samples
Further Publications
Related content
Cardiovascular Risk and Diseases
Associations between insulin resistance indices and cardiovascular disease in older adults with cardiovascular-kidney-metabolic syndrome stage 0-3: The GOLD-Health cohort
Diabetes Res Clin Pract
Wang M, Lin W, Liu H, Qian ZM, Chen J, Rao M, Zhou Q, Zhuang Z, Luo L, Fang Y, Liu X, Burroughs T, McMillin SE, Lin H, Zhang Z, Chen G
doi: 10.1016/j.diabres.2025.112327
Cardiovascular Risk and Diseases
Transition of BMI Status From Childhood to Adulthood and Cardiovascular-Kidney-Metabolic Syndrome in Midlife: A 36-Year Cohort Study
Diabetes Care
Wang Y, Yang Y, Chen J, Du MF, Sun Y, Wang D, Jia H, Hu GL, Man ZY, Zhang T, Zuo SH, Chu C, Chang MK, Niu ZJ, Xiong Y, Li H, Yao S, Chen L, Ren J, Kang YM, Yuan ZY, Wang DL, Lip GYH, Liu Z, Mu JJ
doi: 10.2337/dca25-0027
Atrial Fibrillation
Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled Analysis
J Am Coll Cardiol
Pabon MA, Filippatos G, Claggett BL, Miao MZ, Desai AS, Jhund PS, Henderson A, Brinker M, Schloemer P, Hofmeister L, Li L, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, McMurray JJV, Solomon SD, Vaduganathan M
doi: 10.1016/j.jacc.2025.03.429
Heart Failure
Prognostic Impact of Cardiovascular-Kidney-Metabolic Overlap Among Patients With Acute Heart Failure: Insights From a Real-World Multinational Cohort
J Am Heart Assoc
Marchetti M, Antiochos P, Pitta-Gros B, Abdurashidova T, Soborun N, Monney P, Yerly P, Tzimas G, Skalidis I, Vollenweider P, Gencer B, Fakhouri F, Vaduganathan M, Hullin R, Lu H
doi: 10.1161/JAHA.125.045294
Cardiovascular Risk and Diseases
Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife
JAMA Cardiol
Jhee JH, Ha KH, Son D, Lee HH, Kim EJ, Kim HC, Lee H
doi: 10.1001/jamacardio.2025.3269
COMMENTED
Heart, Artery and Coronary Diseases
Heterogeneity of Cardiovascular Effects of Second-Line Glucose-Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
J Am Heart Assoc
Deng Y, Polley EC, Herrin J, Swarna KS, Kent DM, Ross JS, Maron BA, Mickelson MM, McCoy RG
doi: 10.1161/JAHA.124.040217
Further Publications
End Point-Based Threshold for the Ambulatory Arterial Stiffness Index
Hypertension
Cheng YB, An DW, Zhang DY, Yu YL, Melgarejo JD, Boggia J, Martens DS, Hansen TW, Asayama K, Ohkubo T, Stolarz-Skrzypek K, Huang QF, Malyutina S, Casiglia E, Lind L, Maestre GE, Wang JG, Kikuya M, Kawecka-Jaszcz K, Dolan E, Sandoya E, Rajzer M, Nawrot TS, Narkiewicz K, Yang WY, Verhamme P, Filipovský J, Graciani A, Banegas JR, Li Y, Staessen JA, International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators
doi: 10.1161/HYPERTENSIONAHA.125.25442
Cardiovascular Risk and Diseases
Population-level impact of semaglutide 2.4 mg in patients with obesity or overweight and cardiovascular disease: A modelling study based on the SELECT trial
Diabetes Obes Metab
Nanna MG, Doan QV, Fabricatore A, Faurby M, Henry AD, Houshmand-Oeregaard AS, Levine A, Navar AM, Scassellati Sforzolini T, Toliver JC
doi: 10.1111/dom.16370
Hypertension
Ambulatory blood pressure monitoring, European guideline targets, and cardiovascular outcomes: an individual patient data meta-analysis
Eur Heart J
Zhang DY, An DW, Yu YL, Melgarejo JD, Boggia J, Martens DS, Hansen TW, Asayama K, Ohkubo T, Stolarz-Skrzypek K, Malyutina S, Casiglia E, Lind L, Maestre GE, Wang JG, Imai Y, Kawecka-Jaszcz K, Sandoya E, Rajzer M, Nawrot TS, O'Brien E, Yang WY, Filipovský J, Graciani A, Banegas JR, Li Y, Staessen JA, International Database of Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators
doi: 10.1093/eurheartj/ehaf220